Serotonin potentiates angiotensin II - Induced vascular smooth muscle cell proliferation

Atherosclerosis

Volumn 159, Issue 2, 2001, Pages 269-279

  Watanabe, Takuya ^a   Pakala, Rajbabu ^a   Katagiri, Takashi ^b   Benedict, Claude R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Atherosclerosis; Restenosis; Serotonin; Vascular smooth muscle cell

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; DNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PERTUSSIS TOXIN; RADICICOL; SARPOGRELATE; SEROTONIN; SEROTONIN 2A RECEPTOR; THYMIDINE; TRITIUM;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CELL DIVISION; CELLS, CULTURED; DRUG INTERACTIONS; MALE; MUSCLE, SMOOTH, VASCULAR; PROBABILITY; RABBITS; SENSITIVITY AND SPECIFICITY; SEROTONIN;

EID: 0035202238     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00505-6     Document Type: Article

References (55)

1. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies
2. Smooth muscle DNA replication in response to angiotensin II is regulated differently in the neointima and media at different times after balloon injury in the rat carotid artery: Role of AT1 receptor expression
3. Vascular injury induces angiotensinogen gene expression in the media and neointima
4. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries
5. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist: Effects on smooth muscle cell migration and proliferation after balloon catheter injury
6. Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells
7. Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells
8. Angiotensine II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells
9. Stimulation of platelet-derived growth factor-induced DNA synthesis by angiotensin II in rabbit vascular smooth muscle cells
10. Correlation of plasma serotonin changes and platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation
11. Angiographic demonstration of hyperconstriction induced by serotonin and aggregating platelets in porcine coronary arteries with regenerated endothelium
12. Correlations between pletelet aggregation, fibrinolysis, peripheral and central serotonergic measures in subhuman primates
13. Serotonin is associated with coronary artery disease and cardiac events
14. 2, and specific receptor antagonists on vascular smooth muscle cell proliferation
15. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture
16. Comparison of the mitogenic activity of angiotensin II and serotonin on porcine arterial smooth muscle cells
17. Vascular smooth muscle proliferation: Synergistic interaction between serotonin and low density lipoproteins
18. Effect of ACE inhibitors on oxidation of human low density lipoprotein
19. 1 receptor subtype
20. Effects of an angiotensin II receptor antagonist, CV-111974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells
21. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate
22. Regulation of serotonin-induced DNA synthesis of bovine pulmonary artery smooth muscle cells
23. Serotonin stimulates the expression of thrombin receptors in cultured vascular smooth muscle cells: Role of protein kinase C and protein tyrosine kinases
24. Radicicol leads to selective depletion of Raf kinase and disrupts K-Ras-activaed aberrant signaling pathway
25. 5-Hydroxytryptamine-induced potentiation of endothelin-1- and norepinephrine-induced contraction is mitogenic-activated protein kinase pathway dependent
26. 1 adrenergic receptor and the Jak/STAT signaling pathway in vascular smooth muscle cells
27. Purification of human platelet-derived growth factor
28. Synergy between thrombin and serotonin in inducing vascular vascular smooth muscle cell proliferation
29. A new role for an old molecule: Serotonin as a mitogen
30. 2 receptor mRNA is overexpressed in cultured rat aortic smooth muscle cells relative to normal aorta
31. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: Relationship with the mitogenic action of serotonin
32. Central role of the MAPK pathway in Ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells
33. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: Role of extracellular signal-regulated kinases
34. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
35. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells
36. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells
37. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells
38. Role of mitogen-activated protein kinase in the angiotensin II-induced DNA synthesis in vascular smooth muscle cells
39. The role of angiotensin II in vascular smooth muscle cell growth
40. Angiotensin II signaling in vascular smooth muscle: New concepts
41. Direct stimulation of role of Jak/STAT pathway by the angiotensin II AT1 receptor
42. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation
43. Histamine antagonizes serotonin and growth factor-induced mitogen-activated protein kinase activation in bovine tracheal smooth muscle cells
44. 2A receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle
45. Platelet-derived growth factor mediates angiotensin II-induced DNA synthesis in vascular smooth muscle cells
46. Evidence for the involvement of platelet-derived growth factor in the angiotensin II-induced growth of rat vascular smooth muscle cells
47. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells
48. Angiotensin II and noradrenaline increase PDGF-BB receptors and potentiate PDGF-BB stimulated DNA synthesis in vascular smooth muscle
49. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-β1 expression in vascular smooth muscle cells
50. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: Relationships to neointima formation
51. Vascular smooth muscle cells
52. CV-11974, the active metabolite of TCV-116 (candesartan), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells
53. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate
54. Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-β